The first group to present was Shayna Kay, Amina Ali and Kelly Oyiliagu whose capstone aims to prototype an app to monitor patients for parameters associated with potential adverse effects of CAR T-cell therapy, including cytokine release syndrome, neurotoxicity, and infection. They outlined how they’ve found an industry partner, submitted applications and proposals for funding, and created a project plan and executed aspects of that plan. They also explained their next steps which included designing an app– a main component of their project – as well as stakeholder interviews. In their question period, they were asked about how they will maintain the security of the data they intended to collect.